Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
3.550
-0.110 (-3.01%)
Mar 31, 2025, 1:43 PM EDT - Market open

Amylyx Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Revenue
87.37380.7922.230.290.65
Upgrade
Revenue Growth (YoY)
-77.05%1612.94%7700.00%-56.15%-54.42%
Upgrade
Cost of Revenue
228.72153.6396.4444.0424.59
Upgrade
Gross Profit
-141.35227.16-74.21-43.76-23.94
Upgrade
Selling, General & Admin
114.33188.36127.1338.9315.06
Upgrade
Research & Development
36.2----
Upgrade
Operating Expenses
150.53188.36127.1338.9315.06
Upgrade
Operating Income
-291.8838.8-201.34-82.69-39.01
Upgrade
Interest Expense
-----2.29
Upgrade
Interest & Investment Income
13.8116.164.290.040.01
Upgrade
Other Non Operating Income (Expenses)
-11.07-10.6-2.610.07-1.27
Upgrade
EBT Excluding Unusual Items
-289.1444.36-199.66-82.58-42.55
Upgrade
Merger & Restructuring Charges
-22.85----
Upgrade
Gain (Loss) on Sale of Investments
9.869.942.06-0.12-
Upgrade
Other Unusual Items
----5.230.27
Upgrade
Pretax Income
-302.1454.3-197.6-87.93-42.28
Upgrade
Income Tax Expense
-0.395.030.77--
Upgrade
Net Income
-301.7449.27-198.38-87.93-42.28
Upgrade
Net Income to Common
-301.7449.27-198.38-87.93-42.28
Upgrade
Shares Outstanding (Basic)
68675876
Upgrade
Shares Outstanding (Diluted)
68705876
Upgrade
Shares Change (YoY)
-2.64%19.65%788.13%8.37%3.20%
Upgrade
EPS (Basic)
-4.430.73-3.39-13.35-6.96
Upgrade
EPS (Diluted)
-4.430.70-3.39-13.35-6.96
Upgrade
Free Cash Flow
-204.0110.68-182.4-75.15-36.85
Upgrade
Free Cash Flow Per Share
-2.990.15-3.12-11.41-6.06
Upgrade
Gross Margin
-161.78%59.66%---
Upgrade
Operating Margin
-334.07%10.19%-905.72%-29013.33%-6000.77%
Upgrade
Profit Margin
-345.36%12.94%-892.38%-30852.98%-6504.61%
Upgrade
Free Cash Flow Margin
-233.50%2.80%-820.50%-26369.12%-5668.92%
Upgrade
EBITDA
-290.9839.89-200.85-82.64-39
Upgrade
EBITDA Margin
-10.48%---
Upgrade
D&A For EBITDA
0.91.090.490.050
Upgrade
EBIT
-291.8838.8-201.34-82.69-39.01
Upgrade
EBIT Margin
-10.19%---
Upgrade
Effective Tax Rate
-9.26%---
Upgrade
Revenue as Reported
--22.230.29-
Upgrade
Advertising Expenses
2.79.54.4--
Upgrade
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q